Study of using medicine to boost the appetite in patients with cancer getting treated with chemotherapy
Not Applicable
Completed
- Conditions
- Health Condition 1: C249- Malignant neoplasm of biliary tract, unspecifiedHealth Condition 2: C23- Malignant neoplasm of gallbladderHealth Condition 3: C228- Malignant neoplasm of liver, primary, unspecified as to typeHealth Condition 4: C259- Malignant neoplasm of pancreas, unspecifiedHealth Condition 5: C169- Malignant neoplasm of stomach, unspecifiedHealth Condition 6: C349- Malignant neoplasm of unspecifiedpart of bronchus or lung
- Registration Number
- CTRI/2020/08/027133
- Lead Sponsor
- Jawaharlal Institute of Postgraduate Medical Education and Reseach
- Brief Summary
Not available
- Detailed Description
Not available
Recruitment & Eligibility
- Status
- Completed
- Sex
- Not specified
- Target Recruitment
- 124
Inclusion Criteria
stage 3 or 4 of Gastric Hepatopancreaticobiliary and lung cancer, who are fit for chemotherapy and are able to take oral diet
Exclusion Criteria
a.Patients on adjuvant chemotherapy
b.Patients with concurrent radiotherapy
c.Intake of olanzapine for more than 4 days per month for any other indications
d.On any antipsychotic or antidepressants
e.Use of systemic corticosteroids (prednisolone 5mg or equivalent for more than
7 days in the previous 4 weeks)
f.Ascites at time of enrolment
g.Pregnancy
h.Patients already enrolled in other trails within the past 3 months
Study & Design
- Study Type
- Interventional
- Study Design
- Not specified
- Primary Outcome Measures
Name Time Method
- Secondary Outcome Measures
Name Time Method